» Articles » PMID: 34281286

Norepinephrine Protects Against Methamphetamine Toxicity Through β2-Adrenergic Receptors Promoting LC3 Compartmentalization

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jul 20
PMID 34281286
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Norepinephrine (NE) neurons and extracellular NE exert some protective effects against a variety of insults, including methamphetamine (Meth)-induced cell damage. The intimate mechanism of protection remains difficult to be analyzed in vivo. In fact, this may occur directly on target neurons or as the indirect consequence of NE-induced alterations in the activity of trans-synaptic loops. Therefore, to elude neuronal networks, which may contribute to these effects in vivo, the present study investigates whether NE still protects when directly applied to Meth-treated PC12 cells. Meth was selected based on its detrimental effects along various specific brain areas. The study shows that NE directly protects in vitro against Meth-induced cell damage. The present study indicates that such an effect fully depends on the activation of plasma membrane β2-adrenergic receptors (ARs). Evidence indicates that β2-ARs activation restores autophagy, which is impaired by Meth administration. This occurs via restoration of the autophagy flux and, as assessed by ultrastructural morphometry, by preventing the dissipation of microtubule-associated protein 1 light chain 3 (LC3) from autophagy vacuoles to the cytosol, which is produced instead during Meth toxicity. These findings may have an impact in a variety of degenerative conditions characterized by NE deficiency along with autophagy impairment.

Citing Articles

The brainstem reticular formation pivots abnormal neural transmission in the course of Anorexia Nervosa.

Lazzeri G, Busceti C, Polzella A, Frati A, Puglisi-Allegra S, Fornai F J Neural Transm (Vienna). 2025; 132(4):547-565.

PMID: 39853374 DOI: 10.1007/s00702-025-02881-8.


Modulation of autophagy by melatonin and its receptors: implications in brain disorders.

Zhu C, Li G, Lyu H, Lu Y, Li Y, Zhang X Acta Pharmacol Sin. 2024; 46(3):525-538.

PMID: 39448859 PMC: 11845611. DOI: 10.1038/s41401-024-01398-2.


Methamphetamine Increases Tubulo-Vesicular Areas While Dissipating Proteins from Vesicles Involved in Cell Clearance.

Lazzeri G, Lenzi P, Busceti C, Puglisi-Allegra S, Ferrucci M, Fornai F Int J Mol Sci. 2024; 25(17).

PMID: 39273545 PMC: 11395429. DOI: 10.3390/ijms25179601.


Neuroprotective actions of norepinephrine in neurological diseases.

Ghasemi M, Mehranfard N Pflugers Arch. 2024; 476(11):1703-1725.

PMID: 39136758 DOI: 10.1007/s00424-024-02999-w.


Damage to the Locus Coeruleus Alters the Expression of Key Proteins in Limbic Neurodegeneration.

Biagioni F, Ferrucci M, Lazzeri G, Scioli M, Frati A, Puglisi-Allegra S Int J Mol Sci. 2024; 25(6).

PMID: 38542133 PMC: 10970344. DOI: 10.3390/ijms25063159.


References
1.
Li X, Du Y, Zhang L, Chen X, He D . Chloride channel 7 protects from redox status impairment-induced renal tubular epithelial cell apoptosis by activating autophagy. Life Sci. 2020; 261:118484. DOI: 10.1016/j.lfs.2020.118484. View

2.
Giorgi F, Ryskalin L, Ruffoli R, Biagioni F, Limanaqi F, Ferrucci M . The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. Front Neuroanat. 2017; 11:80. PMC: 5610679. DOI: 10.3389/fnana.2017.00080. View

3.
Szot P, Weinshenker D, White S, Robbins C, Rust N, Schwartzkroin P . Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli. J Neurosci. 1999; 19(24):10985-92. PMC: 6784922. View

4.
Sternberg Z, Schaller B . Central Noradrenergic Agonists in the Treatment of Ischemic Stroke-an Overview. Transl Stroke Res. 2019; 11(2):165-184. DOI: 10.1007/s12975-019-00718-7. View

5.
Cirelli C, Pompeiano M, Tononi G . Neuronal gene expression in the waking state: a role for the locus coeruleus. Science. 1996; 274(5290):1211-5. DOI: 10.1126/science.274.5290.1211. View